Anaphylaxis News and Research

RSS
Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.
Changes to infant gut bacteria and food allergies are linked to C-section birth, ethnicity

Changes to infant gut bacteria and food allergies are linked to C-section birth, ethnicity

Michigan Medicine to kick off first national study on allergic reactions to COVID-19 vaccines

Michigan Medicine to kick off first national study on allergic reactions to COVID-19 vaccines

NIH-funded clinical trial begins study of systemic allergic reactions to COVID-19 vaccines

NIH-funded clinical trial begins study of systemic allergic reactions to COVID-19 vaccines

Study lists five facts to know about antihistamines

Study lists five facts to know about antihistamines

Scientists estimate the amount of peanut protein that will elicit an allergic reaction

Scientists estimate the amount of peanut protein that will elicit an allergic reaction

ChAdOx1 nCoV-19 vaccine does not protect against South African SARS-CoV-2 variant

ChAdOx1 nCoV-19 vaccine does not protect against South African SARS-CoV-2 variant

Study provides accurate data on allergic reactions related to mRNA COVID-19  vaccines

Study provides accurate data on allergic reactions related to mRNA COVID-19 vaccines

AI-mediated analysis of vaccinated patients affirms safety of SARS-CoV-2 vaccines

AI-mediated analysis of vaccinated patients affirms safety of SARS-CoV-2 vaccines

FDA issues EUA for bamlanivimab and etesevimab for COVID-19 treatment

FDA issues EUA for bamlanivimab and etesevimab for COVID-19 treatment

Study reveals new molecular mechanism linked to severe anaphylaxis

Study reveals new molecular mechanism linked to severe anaphylaxis

Commentary on severe allergic reaction to mRNA SARS-CoV-2 vaccines

Commentary on severe allergic reaction to mRNA SARS-CoV-2 vaccines

Novel immunotherapy approach to revert the main hallmarks of cat allergy

Novel immunotherapy approach to revert the main hallmarks of cat allergy

Race may play an important role in children's food allergies

Race may play an important role in children's food allergies

Black children have significantly higher rates of shellfish and fish allergies than white children

Black children have significantly higher rates of shellfish and fish allergies than white children

Specific NSAIDs are metabolized by acyl-CoA synthetases leading to liver toxicity

Specific NSAIDs are metabolized by acyl-CoA synthetases leading to liver toxicity

Is your covid vaccine venue prepared to handle rare, life-threatening reactions?

Is your covid vaccine venue prepared to handle rare, life-threatening reactions?

COVID vaccines appear safe and effective, but key questions remain

COVID vaccines appear safe and effective, but key questions remain

ACAAI releases guidance related to risk of allergic reactions to Pfizer-BioNTech COVID-19 vaccine

ACAAI releases guidance related to risk of allergic reactions to Pfizer-BioNTech COVID-19 vaccine

FDA expands approved indication for influenza treatment to include post-exposure prevention

FDA expands approved indication for influenza treatment to include post-exposure prevention

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer